The interim financial statements are unaudited, but reflect all adjustments which are, in the opinion of management, of a normal, recurring nature necessary to provide a fair statement of results for the interim periods presented.
The Company uses a 52- to 53-week fiscal year ending on the Saturday nearest March 31.
The authoritative guidance provides a five-step process for recognizing revenue that depicts the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
The new authoritative guidance is required to be applied retrospectively to each prior reporting period presented, or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application.
The Company continues to evaluate the impact to revenues and related disclosures related to the pending adoption of the new guidance and the preliminary assessments are subject to change.
The new authoritative guidance also changes certain disclosure requirements and other aspects of current U.S. GAAP.
It does not change the guidance for classifying and measuring investments in debt securities and loans.
Upon adoption, the Company will record all of the unrealized gains or losses from its investment in mutual funds and equity securities to retained earnings, and subsequent changes in fair value from such investments will be recorded under its consolidated statements of income.
Accordingly, a lessee will recognize a lease asset for its right to use the underlying asset and a lease liability for the corresponding lease obligation.
The new authoritative guidance is effective for public business entities for fiscal years beginning after December 15, 2018, and interim periods within those fiscal years, which for Xilinx would be the first quarter of fiscal year 2020.The reader should not place undue reliance on these forward-looking statements.
We disclaim any responsibility to update or revise any forward-looking statement provided in this Management's Discussion and Analysis for any reason.
•Advanced Products include our recent product offerings and include the UltraScale+, UltraScale and 7-series product families."Financial Statements" for information regarding patent litigation.
The following risk factors and other information included in this Quarterly Report on Form 10-Q should be carefully considered.
The risks and uncertainties described below are not the only risks to the Company.
Additional risks and uncertainties not presently known to the Company or that the Company’s management currently deems immaterial also may impair its business operations.
•market acceptance of our customers' products.